If you have been reading about Cyclic AMP and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Last reviewed on 2026-04-30. Where a claim depends on a specific study, the study is described rather than over-claimed.
Reports on this compound commonly follow serum growth hormone and insulin-like growth factor 1 across defined time windows. Protocols differ in sampling frequency, assay platform, and participant characteristics, which makes direct comparison between publications difficult. Some work focuses on pulsatile release patterns instead of average concentrations. Whether repeated exposure alters endogenous hormone rhythms over long periods remains an open question, and the formal literature is thinner than the volume of informal commentary implies.
Once in circulation, the peptide binds the growth hormone-releasing hormone receptor displayed on pituitary somatotroph cells. Receptor activation couples to Gs proteins, elevates intracellular cyclic AMP, and drives protein kinase A signaling inside the cell. That cascade increases discharge of growth hormone into the bloodstream. The analog therefore operates through a receptor pathway that already exists for the body's own releasing hormone, rather than through an engineered artificial target.
Clearance profiles diverge sharply between the two versions. The albumin-binding molecule stays in plasma for several days, whereas the unmodified analog is largely gone within about half an hour in reported work. Cleavage by dipeptidyl peptidase IV is a major contributor to the short life of the unmodified sequence. These gaps mean the two versions cannot be substituted for each other in study design or in reading results side by side.
The drug affinity complex is a maleimidopropionic acid group attached to a lysine side chain. It reacts with the free thiol of cysteine-34 on circulating albumin, forming a covalent bond. This conjugation keeps the peptide in the bloodstream and shields it from rapid renal filtration and proteolysis. Reported circulation half-lives for the albumin-bound form fall in the range of roughly six to nine days in early human studies.
Binding to GHRH receptors on pituitary somatotroph cells triggers cyclic AMP signaling and stimulates growth hormone synthesis and release. Because the peptide acts upstream of the pituitary, effects are mediated through endogenous growth hormone rather than direct receptor activation in peripheral tissues. Increases in insulin-like growth factor 1 are generally described as a downstream consequence. Most published human exposure data come from small early-stage studies, and the clinical significance of the pharmacokinetic profile remains incompletely characterized.
| Property | Value | Notes |
|---|---|---|
| Primary target | GHRH receptor | Present on pituitary somatotroph cells |
| Signal pathway | Gs, cyclic AMP, protein kinase A | Sequence follows receptor activation |
| Main measured effect | Growth hormone release | Insulin-like growth factor 1 shifts indirectly |
| Half-life, binding form | Several days | Extended through serum albumin association |
| Half-life, unmodified form | About 30 minutes | Limited mainly by enzymatic cleavage |
=== Ion Physics Corporation === Ion Physics Corporation (IPC), an HVEC subsidiary, conducted the first commercial research in ion implantation, a technique that became essential to semiconductor manufacturing worldwide. IPC originated in 1959 as a joint venture with B.F. Goodrich to develop ion propulsion for spacecraft. The venture delivered an experimental ion engine to the Jet Propulsion Laboratory for testing. After HVEC bought out Goodrich in 1962, the subsidiary was renamed Ion Physics Corporation and pivoted toward ion bombardment techniques for fabricating solar cells and other semiconductor devices. Using Van de Graaff accelerators to implant ions into silicon wafers, IPC achieved several advances by the mid-1960s: a new efficiency record for silicon solar cells, the first bipolar transistor made from ion-implanted junctions, and annealing processes to repair crystal damage caused by bombardment. In 1969, Fairchild Semiconductor contracted with HVEC for a low-energy ion accelerator. Peter Rose, HVEC's research director, built a functional prototype in six weeks from stockroom parts. The machine demonstrated that ion implantation could precisely control the placement and quantity of dopant atoms in silicon—offering finer control over transistor characteristics than traditional diffusion techniques. IPC itself failed to commercialize the technology. After three executives resigned in late 1969, Rose was appointed president, but the subsidiary continued to struggle. In 1971, Rose left to found Extrion Corporation with HVEC backing and IPC closed the same year.
Similarly to the SIR model, also, in this case, we have a Disease-Free-Equilibrium (N,0,0,0) and an Endemic Equilibrium EE, and one can show that, independently from biologically meaningful initial conditions
=== Phase transitions === The melting point of crystallized honey is between 40 and 50 °C (104 and 122 °F), depending on its composition. Below this temperature, honey can be either in a metastable state, meaning that it will not crystallize until a seed crystal is added, or, more often, it is in a "labile" state, being saturated with enough sugars to crystallize spontaneously. The rate of crystallization is affected by many factors, but the primary factor is the ratio of the main sugars: fructose to glucose. Honeys that are supersaturated with a very high percentage of glucose, such as brassica honey, crystallize almost immediately after harvesting, while honeys with a low percentage of glucose, such as chestnut or tupelo honey, do not crystallize. Some types of honey may produce few but very large crystals, while others produce many small crystals. Crystallization is also affected by water content, because a high percentage of water inhibits crystallization, as does a high dextrin content. Temperature also affects the rate of crystallization, with the fastest growth occurring between 13 and 17 °C (55 and 63 °F). Crystal nuclei (seeds) tend to form more readily if the honey is disturbed, by stirring, shaking, or agitating, rather than if left at rest. However, the nucleation of microscopic seed-crystals is greatest between 5 and 8 °C (41 and 46 °F). Therefore, larger but fewer crystals tend to form at higher temperatures, while smaller but more-numerous crystals usually form at lower temperatures.
=== Hybrid === When the parent anticyclone is weaker or not ideally located, the diabatic process must start to contribute in order to develop CAD. In scenarios where there is an equal contribution from dry synoptic forcing and diabatic processes, it is considered a hybrid damming event. The 250-mb jet is weaker and slightly farther south relative to a classical composite 24 hours prior to CAD onset. With the surface parent high farther west, it builds in eastward into the northern Great Plains and western Great Lakes region, located beneath a region of confluent flow from the 250-mb jet.
Sources: en.wikipedia.org
However, it is possible that some isotopes that are now considered stable will be revealed to decay with extremely long half-lives (as happened with bismuth). For each of the 80 stable elements, the number of stable isotopes is given. Only 90 isotopes are stable against any possible decay, and an additional 161 are energetically unstable (see List of nuclides) but have never been observed to decay. Thus, 251 isotopes (nuclides) are stable by definition (including an excited state, tantalum-180m, for which no decay has yet been observed). In April 2019 it was announced that the half-life of xenon-124 had been measured to 1.8 × 1022 years. This is the longest half-life directly measured for any unstable isotope; only the (indirectly measured) half-life of tellurium-128 is longer. Of the chemical elements, only 1 element (tin) has 10 such stable isotopes, 5 have 7 stable isotopes, 7 have 6 stable isotopes, 11 have 5 stable isotopes, 9 have 4 stable isotopes, 5 have 3 stable isotopes, 16 have 2 stable isotopes, and 26 have 1 stable isotope. Additionally, 31 nuclides of the naturally occurring elements have unstable isotopes with a half-life long enough to have survived for the age of the Solar System (108 years or more), and an additional four such nuclides represent three elements (bismuth, thorium, uranium) having no stable isotope. These 35 radioactive naturally occurring nuclides comprise the radioactive primordial nuclides. The total number of primordial nuclides is then 251 (the stable nuclides) plus the 35 radioactive primordial nuclides, for a total of 286.
== Function == NPR1 is a membrane-bound guanylate cyclase that serves as the receptor for both atrial and brain natriuretic peptides (ANP and BNP, respectively). It is localized in the kidney where it results in natriuresis upon binding to natriuretic peptides. However, it is found in even greater quantity in the lungs and adipocytes.
=== Sport === Donough O'Brien (1879–1953), was a Welsh-born Irish cricketer. Ray Williams (born 1959), is a weightlifting Commonwealth Games gold medallist. Tony Roberts (born 1969), is Welsh international footballer with 614 club caps Gareth Evans (born 1986), weightlifter, Commonwealth gold medalist and 2012 Summer Olympics, lives in the town. Alex Lynch (born in 1995), a footballer with over 100 club caps, educated in Ysgol Uwchradd Caergybi.
=== Familial dysautonomia === Familial dysautonomia is a genetic condition that can be associated with a lack of overflow tears (alacrima) during emotional crying. Obstruction of the punctum, nasolacrimal canal, or nasolacrimal duct can cause even normal levels of the basal tear to overflow onto the face (epiphora), giving the appearance of constant psychic tearing. This can have significant social consequences.
Journal of Molecular Biology. 206 (4): 759–777. doi:10.1016/0022-2836(89)90583-4. PMID 2500530. Milner-White, E (1990). "Situations of gamma-turns in proteinsTheir relation to alpha-helices, beta-sheets and ligand binding sites". J. Mol. Biol. 216 (2): 385–397. doi:10.1016/S0022-2836(05)80329-8. PMID 2254936. Hutchinson, E.G.; Thornton, J.M. (1994). "A revised set of potentials for β-turn formation in proteins". Protein Science. 3 (12): 2207–2216. doi:10.1002/pro.5560031206. PMC 2142776. PMID 7756980. Pavone V, Gaeta G, Lombardi A, Nastri F, Maglio O, Isernia C, Saviano M (1996). "Discovering protein secondary structures: classification and description of isolated alpha-turns". Biopolymers. 38 (6): 705–21. doi:10.1002/(SICI)1097-0282(199606)38:6<705::AID-BIP3>3.0.CO;2-V. PMID 8652792. Rajashankar KR, Ramakumar S (1996). "Pi-turns in proteins and peptides: Classification, conformation, occurrence, hydration and sequence". Protein Sci. 5 (5): 932–46. doi:10.1002/pro.5560050515. PMC 2143406. PMID 8732765.{{cite journal}}: CS1 maint: deprecated archival service (link) Shapovalov, M; Vucetic, S; Dunbrack RL, Jr (March 2019). "A new clustering and nomenclature for beta turns derived from high-resolution protein structures". PLOS Computational Biology. 15 (3) e1006844. Bibcode:2019PLSCB..15E6844S. doi:10.1371/journal.pcbi.1006844. PMC 6424458. PMID 30845191.
Sources: en.wikipedia.org
It acts on the growth hormone-releasing hormone receptor found on pituitary somatotroph cells. Activation of that receptor triggers growth hormone release through a cyclic AMP dependent pathway.
It links the peptide to serum albumin after administration, which delays removal from circulation. Reported half-life shifts from roughly half an hour to several days as a result.
Most published work tracks serum growth hormone and insulin-like growth factor 1 over time. Sampling schedules and assay methods vary enough that figures are not directly comparable across reports.
The two share the same 29-amino-acid backbone. CJC-1295 carries an additional albumin-binding moiety that markedly extends its residence time in circulation, while the form without that moiety clears faster. Literature sometimes applies the name loosely to either variant.